CORCEPT THERAPEUTICS PUBLISHES ABSTRACT IN THE JOURNAL OF THE ENDOCRINE SOCIETYGlobeNewsWire • 04/01/20
Corcept (CORT) Down 24.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/21/20
Corcept Therapeutics, Inc. (CORT) CEO Joseph Belanoff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/21/20
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue GuidanceGlobeNewsWire • 01/30/20
Despite The Clouds Hanging Over Korlym Sales, Corcept Therapeutics Still Looks An Attractive InvestmentSeeking Alpha • 01/17/20
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/09/19
Corcept Therapeutics (CORT) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/08/19
Corcept (CORT) Up 15.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/31/19
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s SyndromeGlobeNewsWire • 08/28/19